Low expression of miR-150 in pediatric intestinal Burkitt lymphoma (Q39016934)

8 September 2017

Low expression of miR-150 in pediatric intestinal Burkitt lymphoma (English)

1 reference

8 September 2017

0 references

Miao Wang

1

1 reference

8 September 2017

Wenping Yang

series ordinal

2

1 reference

8 September 2017

Min Li

series ordinal

3

1 reference

8 September 2017

Yong Li

series ordinal

4

1 reference

8 September 2017

6 March 2014

1 reference

Experimental and Molecular Pathology

8 September 2017

1 reference

8 September 2017

96

1 reference

8 September 2017

2

1 reference

8 September 2017

261-266

1 reference

Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers

8 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

MicroRNA signatures in human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

Widespread microRNA repression by Myc contributes to tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

Re-expression of microRNA-150 induces EBV-positive Burkitt lymphoma differentiation by modulating c-Myb in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

Histopathology and immunohistochemistry in distinguishing Burkitt lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern: a comparative study with EBER and FISH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt's lymphoma in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

Intestinal perforation after treatment of Burkitt's lymphoma: case report and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

MicroRNAs: small RNAs with a big role in gene regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

A microRNA polycistron as a potential human oncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

Raji revisited: cytogenetics of the original Burkitt's lymphoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

Rituximab combined with autologous peripheral blood stem cell transplantation improve therapeutic effects of chemotherapy in pediatric patients with Burkitt's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

Comparative mRNA and microRNA expression profiling of three genitourinary cancers reveals common hallmarks and cancer-specific molecular events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

MicroRNA expression profiles classify human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

Morphological, immunophenotypic and molecular characterization of mature aggressive B-cell lymphomas in Chinese pediatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

c-Myb contributes to G2/M cell cycle transition in human hematopoietic cells by direct regulation of cyclin B1 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

Life-threatening hyponatraemia and neurotoxicity during chemotherapy for Burkitt's lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

MiRNA profiling in B non-Hodgkin lymphoma: a MYC-related miRNA profile characterizes Burkitt lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

JNK is constitutively active in mantle cell lymphoma: cell cycle deregulation and polyploidy by JNK inhibitor SP600125.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

ALK amplification and protein expression predict inferior prognosis in neuroblastomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

The role of microRNA-150 as a tumor suppressor in malignant lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.015

10.1016/J.YEXMP.2014.02.015

7 January 2021

Identifiers

DOI

1 reference

8 September 2017

1 reference